Product
PBP1510
1 clinical trial
1 indication
Indication
Pancreatic CancerClinical trial
A First in Human, Phase 1/2a, Multicentre, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of PBP1510 in Patients With Advanced/Metastatic Pancreatic CancerStatus: Recruiting, Estimated PCD: 2026-02-01